|
Children
from Indigenous communities were among the first
groups targeted to receive hepatitis B virus (HBV)
vaccination in Australia because of a greater
risk of infection from HBV.
This
project, within the ABC study, will measure the
current prevalence of HBV infection and long term
(>10 years) persistence of HBV antibody in
indigenous adolescents for the first time in Australia
and the response to an HBV vaccine booster dose
in children who have low immunity.
These
long term follow up data on one of the first groups
to be targeted by the National Immunisation Program
are important as adolescence is a time of increased
risk of hepatitis B transmission.
If
clinically significant HBV infections are found
to be rare and immunologic memory can be demonstrated
in this cohort, this would provide good evidence
to support the argument that booster doses are
not required in the Australian context.
Internationally,
this study will add to the limited information
about anamnestic responses to hepatitis B vaccine
in Indigenous adolescents initially vaccinated
at birth.
|